BioSpace News Archive

Amgen (NASDAQ: AMGN) today announced positive topline Phase 2 results from the CodeBreaK 100 clinical study, evaluating sotorasib (proposed INN for AMG 510) in 126 patients with KRAS G12C-mutant advanced non-small cell lung cancer (NSCLC), who had failed a median of two prior lines of anti-cancer therapies (immunotherapy and/or chemotherapy).

GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that the U.S. Food and Drug Administration (FDA) has granted the Company a Rare Pediatric Disease designation for rivipansel for the treatment of sickle cell disease in patients 18 years old and younger.

Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its third quarter 2020 financial results on Thursday, October 29, 2020, prior to its earnings call at 8:00 a.m. ET

Medtronic plc (NYSE:MDT) announced today that the company will host its biennial Institutional Investor and Analyst Event on Wednesday, October 14, 2020, from 8:00 a.m. to approximately 2:00 p.m. Eastern Daylight Time (7:00 a.m. to approximately 1:00 p.m. Central Daylight Time)

Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, announced that management will participate in the following investor conferences in October 2020:

Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced the issuance of its United States Patent No: 10,779,954 entitled “Body Density Scan Result-Matched Orthopedic Implants and Methods of Use” for The World’s First DEXA Technology™ Patient-Matched Implant Technology.

AMAG Pharmaceuticals, Inc. announced that it received a notice from the U.S. Food and Drug Administration that the FDA is proposing to withdraw approval of Makena®, a treatment approved to reduce preterm birth in pregnant women who have had a prior spontaneous preterm birth.

Document Security Systems, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating businesses focusing on brand protection technology, blockchain security, direct marketing, healthcare, real estate, and securitized digital assets, today announced its wholly owned subsidiary Impact BioMedical, Inc. (“Impact BioMedical”)

Cobra Biologics (Cobra), part of the Cognate BioServices family, an international CDMO manufacturer of biological materials and pharmaceuticals, and Scancell Holdings plc (Scancell), the developer of novel immunotherapies for the treatment of cancer and infectious disease, today announced that they have entered into a collaboration for Cobra to manufacture Scancell’s COVID-19 vaccine.

New York Lawsuit Filed Against Regeneron Pharmaceuticals, Inc. California Lawsuit Filed Against Pfizer, Inc. and BioNTech SE and BioNTech U.S., Inc. SAN DIEGO--( BUSINESS WIRE )-- Allele Biotechnology and Pharmaceuticals, Inc. (“Allele”), a San Diego-based company focused on developing and adapting cutting edge technology for clinical and therapeutic use, filed two patent infringement lawsuits today – one in New York against Regenero